Home > Authorities > Institutes > Record #113711 |
G170
Experimentelle Therapien hämatologischer Neoplasien Also known as:G170ID | I:(DE-He78)G170-20160331 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Dissertation / PhD Thesis
Signaling Pathway Profiling in Multiple Myeloma
Dissertation, Universität Heidelberg, 2018
BibTeX |
EndNote:
XML,
Text |
RIS
Dissertation / PhD Thesis
The influence of centrosome amplification and clustering on cell migration and invasion
Dissertation, Universität Heidelberg, 2018
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Oncogene-induced senescence: a potential breakpoint mechanism against malignant transformation in plasma cell disorders.
Leukemia and lymphoma 59(11), 2660 - 2669 (2018) [10.1080/10428194.2018.1443450]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.
The New England journal of medicine 379(19), 1811 - 1822 (2018) [10.1056/NEJMoa1805762]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Blood 132(6), 587-597 (2018) [10.1182/blood-2018-03-840132]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance.
Leukemia 32(12), 2717-2719 (2018) [10.1038/s41375-018-0202-1]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma.
Blood advances 2(1), 1 - 9 (2018) [10.1182/bloodadvances.2017013334]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
The orally available multikinase inhibitor regorafenib (BAY 73-4506) in multiple myeloma.
Annals of hematology 97(5), 839-849 (2018) [10.1007/s00277-018-3237-5]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Therapeutic monoclonal antibodies in combination with pomalidomide can overcome refractoriness to both agents in multiple myeloma: A case-based approach.
Hematological oncology 36(1), 258 - 261 (2018) [10.1002/hon.2473]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Analysis of long-term survival in multiple myeloma after first-line autologous stem cell transplantation: impact of clinical risk factors and sustained response.
Cancer medicine 7(2), 307 - 316 (2018) [10.1002/cam4.1283]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |